🏛️ Verified NIH Record • Updated 2026-03-18
RT-310 Safety and Feasibility BPH Study (NCT07264205)
Safety and Feasibility Study of RT-310 for Treatment of Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH)
🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic Sponsor: Resurge Therapeutics Inc.
🩺 Plain-English Summary (8th-Grade Level)
RT-310, is intended to deliver drug locally to the prostate gland for the management of prostate disease, while minimizing systemic exposure and its associated side-effects. The objectives of the study are to assess whether RT-310 is safe and feasible for the participant population.
Who can join: Review the eligibility criteria below.
Location: Research Site — Santo Domingo
Age range: 50 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Research Site — Santo Domingo,
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in BPH (Benign Prostatic Hyperplasia)
- Butterfly Pivotal Study — New York, New York
- Evaluation of the Impact of Preoperative Pelvic Floor Exercise on Incontinence After Laser Enucleation of the Prostate: a Feasibility Study. — Montreal, Quebec
- Prospective Post Market Clinical Registry for the Zenflow Spring System - A Minimally Invasive Treatment for LUTS Associated With BPH Spring System Registry — La Mesa, California
- New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia — Boston, Massachusetts
- Use of PuraStat Following Aquablation to Determine if There is Change in Hematuria & Probability of Same Day Discharge — Glenview, Illinois
Explore by condition: All BPH (Benign Prostatic Hyperplasia) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.